A Peer to Peer Research Atmosphere Designed to Encourage and Stimulate Product Research While Maximizing Cost Efficiency
Nuovo Biologics is conducting multiple clinical studies, including pilot and pivotal trials, in order to support safety and bio-efficacy for several viral disease indications for dogs, cats, and horses to meet FDA New Animal Drug guidance requirements. The Company is also seeking investigators to participate in clinical studies to treat canine malignant melanoma.
Pilot Studies Are Ongoing
Pivotal and RXE Studies scheduled to start in early 2016.
If you have an interest in seeking further information or in participating in these clinical studies or trials, please click here.
Veterinarians, we are interested in your opinion! Please click here to take our survey.
Your information will not be shared.